NATALIE ZAMEROSKI: Open Payments
NPI 1912578378 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 33 payments from 11 companies in 2025. Trend: 2023 $2,749 · 2024 $3,192 · 2025 $1,302
Food & beverage: $1,218Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $358 |
| ABBVIE INC. | 12 | $357 |
| Janssen Scientific Affairs, LLC | 3 | $184 |
| Ardelyx, Inc. | 2 | $130 |
| EVOKE PHARMA, INC. | 1 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, RINVOQ, IBSRELA, GIMOTI, ENTYVIO, REZDIFFRA, INJECTAFER.
Industry payments across MI — which companies pay providers there.
